RecruitingOBSERVATIONAL

Giessen Pulmonary Hypertension in Lung Cancer Registry

This study, called the Giessen Pulmonary Hypertension in Lung Cancer Registry, aims to understand how common a condition called pulmonary hypertension is in people who have lung cancer. Pulmonary hypertension is when there's high blood pressure in the arteries that carry blood from your heart to your lungs. Doctors at Giessen University Hospital will collect information from all their lung cancer patients as part of their regular care. They want to see if there's a link between lung cancer and pulmonary hypertension. This is an observational study, which means no special treatments or tests will be given; doctors will simply use information they already gather during normal treatment. The goal is to learn more about this connection to help future patients.

At a glance

Status

Recruiting

Sponsor

University of Giessen

Enrolment target

500

Start

29 Jun 2020

Estimated completion

29 Jan 2040

Pulmonary Hypertension Due to Lung Diseases and Hypoxia

What is this study about?

Doctors at Giessen University Hospital are running a study to learn more about lung cancer and a condition called pulmonary hypertension. Pulmonary hypertension means that the blood pressure in the special arteries that go from your heart to your lungs is too high. This can make your heart work harder and can sometimes cause breathlessness. The aim of this study is to see how often people with lung cancer also have pulmonary hypertension.

To do this, the research team will collect information from adult patients who are already being treated for lung cancer at their hospital. They'll look at routine health information that doctors already gather during your regular check-ups and treatments. They are not asking you to do any extra tests, appointments, or take new medicines. Everything will be based on your usual care.

This study is important because understanding if pulmonary hypertension commonly affects people with lung cancer could help doctors spot it earlier or manage care better in the future. By gathering this information, they hope to build a clearer picture of how these conditions might be connected and ultimately improve the health and well-being of lung cancer patients.

Key takeaways

This study looks at how often high blood pressure in the lungs (pulmonary hypertension) occurs in people with lung cancer.
It's a registry study, meaning doctors will collect information from existing patient records.
No extra tests, appointments, or treatments are involved.
Only adult lung cancer patients receiving care at Giessen University Hospital are included.
The aim is to improve understanding and potentially future care for lung cancer patients.
Your medical care will not be affected by participating.

Who may be eligible?

To be part of this study, you need to be an adult patient (aged 18 or older) who is currently receiving treatment for lung cancer at the University of Giessen Lung Cancer Center.

There are no specific reasons why someone would be excluded from participating, as long as they meet the main requirement of being a lung cancer patient at this particular hospital.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Am I 18 years old or older?
Do I have lung cancer?
Am I being treated for lung cancer at the University of Giessen Lung Cancer Center?
Do I understand that no extra tests or treatments are involved?

Answer every question to see your result.

What does participation involve?

If you are a lung cancer patient at Giessen University Hospital and decide to take part in this registry study, you won't need to do anything extra. There are no additional visits, special tests, or new medications involved. The study will simply use information that your doctors already collect during your regular course of treatment for lung cancer. This means your care will stay exactly the same, whether you participate or not. The researchers will look at your existing medical records to understand more about pulmonary hypertension in lung cancer patients.

Potential risks and benefits

Since this study only involves looking at information from your existing medical records, there are no direct physical risks to you. Your personal information will be kept private and handled carefully. The main benefit is that your information, combined with that of many other patients, could help doctors learn more about how lung cancer and pulmonary hypertension are linked. This knowledge could lead to better understanding and possibly better care for future patients. You are always free to decide not to have your information used in this study without it affecting your medical care in any way.

Locations (1)

University hospital Giessen
Verified postcode
Giessen, Germany· Recruiting

Common questions

What is pulmonary hypertension?

Pulmonary hypertension means you have high blood pressure in the arteries that carry blood from your heart to your lungs.

Will I have to take new medicine?

No, this study doesn't involve any new medicines, treatments, or extra tests. Your care will be exactly as it is now.

Will this study change my lung cancer treatment?

No, this study is about collecting information; it will not change your current lung cancer treatment or care plan at all.

Who can join this study?

Adult patients (18 and older) who are being treated for lung cancer at Giessen University Hospital can be included.

Will my information be kept private?

Yes, all your health information used in this study will be kept confidential and handled securely.

How to find out more

Bastian Eul, MD

bastian.eul@innere.med.uni-giessen.de (+49) 0641/985-42371 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.